• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What Is Chronic or Persistent Diabetic Macular Edema and How Should It Be Treated?

作者信息

Apte Rajendra S

机构信息

Washington University School of Medicine, St Louis, Missouri.

出版信息

JAMA Ophthalmol. 2016 Mar;134(3):285-6. doi: 10.1001/jamaophthalmol.2015.5469.

DOI:10.1001/jamaophthalmol.2015.5469
PMID:26746003
Abstract
摘要

相似文献

1
What Is Chronic or Persistent Diabetic Macular Edema and How Should It Be Treated?什么是慢性或持续性糖尿病性黄斑水肿，应如何治疗？
JAMA Ophthalmol. 2016 Mar;134(3):285-6. doi: 10.1001/jamaophthalmol.2015.5469.
2
RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better.糖尿病性黄斑水肿治疗期间视网膜各层对雷珠单抗的反应：并非越薄越好。
Retina. 2016 Jul;36(7):1314-23. doi: 10.1097/IAE.0000000000000923.
3
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.阿柏西普、贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿的比较：数据外推至临床实践
JAMA Ophthalmol. 2016 Jan;134(1):95-9. doi: 10.1001/jamaophthalmol.2015.4110.
4
The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.雷珠单抗治疗前后糖尿病性黄斑水肿患者的黄斑功能与结构
Doc Ophthalmol. 2016 Apr;132(2):111-22. doi: 10.1007/s10633-016-9531-4. Epub 2016 Mar 21.
5
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.抗 VEGF 药物治疗糖尿病黄斑水肿初始疗效有限患者的视力和解剖学结局： RIDE 和 RISE 研究
Ophthalmology. 2016 Jun;123(6):1345-50. doi: 10.1016/j.ophtha.2016.02.007. Epub 2016 Mar 15.
6
Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.患者报告的视觉功能结果在接受雷珠单抗治疗后改善，这些患者因糖尿病性黄斑水肿而视力受损：随机临床试验。
JAMA Ophthalmol. 2013 Oct;131(10):1339-47. doi: 10.1001/jamaophthalmol.2013.4592.
7
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.既往抗血管内皮生长因子治疗持续性糖尿病黄斑水肿后改用阿柏西普治疗
Am J Ophthalmol. 2016 Apr;164:118-27.e2. doi: 10.1016/j.ajo.2015.12.030. Epub 2015 Dec 31.
8
Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.玻璃体内注射雷珠单抗治疗既往已行玻璃体切割术的糖尿病性黄斑水肿。
Acta Ophthalmol. 2017 Feb;95(1):28-32. doi: 10.1111/aos.13160. Epub 2016 Jul 30.
9
Drilling Deeper for Treatment Choices in Diabetic Macular Edema.深入探究糖尿病性黄斑水肿的治疗选择
JAMA Ophthalmol. 2016 Feb;134(2):135-6. doi: 10.1001/jamaophthalmol.2015.4652.
10
Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema.糖尿病性黄斑水肿患者从雷珠单抗转换为阿柏西普治疗的临床真实世界结果。
Eye (Lond). 2017 Nov;31(11):1629-1630. doi: 10.1038/eye.2017.122. Epub 2017 Jun 16.

引用本文的文献

1
Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor.COVID-19封锁期间为患者提供延迟玻璃体内抗VEGF治疗：一项符合伦理的努力。
Clin Ophthalmol. 2021 Feb 17;15:661-669. doi: 10.2147/OPTH.S289068. eCollection 2021.
2
FGF2-induced STAT3 activation regulates pathologic neovascularization.FGF2 诱导的 STAT3 激活调节病理性血管生成。
Exp Eye Res. 2019 Oct;187:107775. doi: 10.1016/j.exer.2019.107775. Epub 2019 Aug 23.
3
VEGF in Signaling and Disease: Beyond Discovery and Development.
血管内皮生长因子在信号转导和疾病中的作用：超越发现和开发。
Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021.
4
Combined SIRT3 and SIRT5 deletion is associated with inner retinal dysfunction in a mouse model of type 1 diabetes.联合 SIRT3 和 SIRT5 缺失与 1 型糖尿病小鼠模型的内视网膜功能障碍有关。
Sci Rep. 2019 Mar 7;9(1):3799. doi: 10.1038/s41598-019-40177-6.
5
Management of diabetic macular edema in Japan: a review and expert opinion.日本糖尿病性黄斑水肿的管理：综述与专家意见
Jpn J Ophthalmol. 2018 Jan;62(1):1-23. doi: 10.1007/s10384-017-0537-6. Epub 2017 Dec 5.
6
Identification of time point to best define 'sub-optimal response' following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data.基于真实世界数据确定玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿后最能定义“次优反应”的时间点。
Eye (Lond). 2017 Nov;31(11):1594-1599. doi: 10.1038/eye.2017.111. Epub 2017 Jun 16.
7
Clinical utility of intravitreal fluocinolone acetonide (Iluvien) implant in the management of patients with chronic diabetic macular edema: a review of the current literature.玻璃体内注射曲安奈德（Iluvien）植入物在慢性糖尿病性黄斑水肿患者治疗中的临床应用：当前文献综述
Clin Ophthalmol. 2017 Mar 27;11:583-590. doi: 10.2147/OPTH.S131165. eCollection 2017.